Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2-negative breast cancer: study protocol for a randomized pilot trial.

Saved in:

Bibliographic Details
Title:	Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2-negative breast cancer: study protocol for a randomized pilot trial.
Authors:	Wei Wu¹, Heran Deng¹, Nanyan Rao¹, Na You², Yaping Yang¹, Minghui Cao³ mzk@126.com, Jieqiong Liu¹ liujieqiong01@163.com, Wu, Wei⁴ (AUTHOR), Deng, Heran⁴ (AUTHOR), Rao, Nanyan⁴ (AUTHOR), You, Na⁵ (AUTHOR), Yang, Yaping⁴ (AUTHOR), Cao, Minghui⁶ (AUTHOR), Liu, Jieqiong⁴ (AUTHOR)
Source:	Trials. 10/25/2017, Vol. 18, p1-6. 6p. 2 Charts.
Database:	Academic Search Ultimate

Description
ISSN:	17456215
DOI:	10.1186/s13063-017-2228-5